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HuskinDB, a database for skin 
permeation of xenobiotics
Dmitri Stepanov1, Steven Canipa2 & Gerhard Wolber  1 ✉
Skin permeation is an essential biological property of small organic compounds our body is exposed 
to, such as drugs in topic formulations, cosmetics, and environmental toxins. Despite the limited 
availability of experimental data, there is a lack of systematic analysis and structure. We present a 
novel resource on skin permeation data that collects all measurements available in the literature and 
systematically structures experimental conditions. Besides the skin permeation value kp, it includes 
experimental protocols such as skin source site, skin layer used, preparation technique, storage 
conditions, as well as test conditions such as temperature, pH as well as the type of donor and acceptor 
solution. It is important to include these parameters in the assessment of the skin permeation data. In 
addition, we provide an analysis of physicochemical properties and chemical space coverage, laying 
the basis for applicability domain determination of insights drawn from the collected data points. 
the database is freely accessible under https://huskindb.drug-design.de or https://doi.org/10.7303/
syn21998881.
Background & Summary
Skin is the biggest organ in the human body. It provides a physical barrier to external influences, contributes to 
the metabolising and excretory functions and can absorb chemical substances. Skin has a layered structure, and it 
is assumed that a chemical compound, which permeates all layers of epidermis, the uppermost layer of the skin, 
is being fully carried away into the bloodstream by the capillaries of the dermis1. The transport itself is driven by 
a concentration gradient, and the classical model of permeation describes three absorption pathways: intracel-
lular, intercellular and follicular. Investigation of skin permeation properties of chemical compounds is crucial 
for occupational exposure risk assessment and cosmetic and pharmaceutical development1. For this reason, skin 
permeation by xenobiotics has been investigated for many years2–9. Despite the time and cost intensiveness of the 
necessary experiments to determine skin permeation properties, the amount of data in the public domain has 
been steadily growing. This enabled research groups to collect enough data to develop predictive mathematical 
models. Different modelling approaches were implemented using a multitude of algorithms and data handling 
procedures. For example, Bratt et al.10, used permeation values from the Flynn dataset11 and removed values, that 
did not fit the overall data, leaving 60 data points. Chen et al.12 used permeation data on 215 compounds as a tar-
get value and did not report any outlier handling. Degim et al.13 used data on 40 substances and did not describe 
any outlier handling steps. A publication by Tsakovska et al.14 gives a comprehensive overview of these and other 
record collections.
A careful and thorough analysis of all these approaches revealed that most existing datasets such as the ones 
compiled by Flynn et al.11 or Wilschut et al.15 do not contain the experimental conditions under which the skin 
permeability measurements were obtained. Others, like the once created by Vecchia et al.16 or Magnusson et al.17 
include experimental parameters. One of the most comprehensive data collections is the EDETOX database18 
which returns 537 data points when querying in vitro measurements done with human skin. Not all of these data 
points, however, contain the skin permeation value (or steady-state flux and concentration of the chemical which 
can be used to calculate skin permeation). Apart from that, EDETOX does not contain the information on the 
skin source: whether the skin was obtained post-mortem from a cadaver or during a cosmetical procedure. No 
database containing all experimental conditions and skin permeation records exists to date. Additionally, when 
carefully comparing and analysing published datasets, inconsistencies can be identified, such as different or sim-
ply copied values. For example, Patel et al. used a logkp value for 2-ethoxyethanol of −7.16 (cm/s). This value was 
also used by Baba et al.19, Neely et al. (OSU-KP)20, Chen et al.12 and Lian et al.21. In contrast, Brown et al.22 used a 
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logkp value of −6.92 (cm/s). For corticosterone Wilschut et al.15 and Patel et al.23 both used a logkp value of −7.78 
(cm/s), but Baba et al.19 and Lian et al.21 used a value of −7.08 (cm/s), whereas Lian et al. included additional 
values of −7.56 (cm/s) and −6.81 (cm/s). In addition to this, different research groups used different measuring 
units. Wilschut et al. used kp measured in cm/h, Patel et al. logkp in cm/h and Lian et. al. logkp in cm/s. It is also 
important to consider that different layers of epidermis have different properties in regard to skin permeation: the 
hydrophobic stratum corneum is a barrier for hydrophilic substances. The hydrophilic viable epidermis, which is 
positioned under the stratum corneum, represents a barrier to hydrophobic substances. Thus, it is important to 
consider, which layer of the skin was used to obtain experimental data when analysing skin permeation values.
In this study, we present a novel comprehensive database of skin permeation values and corresponding exper-
imental protocols. This manually curated database is a result of an extensive and careful analysis of previously 
published human skin permeation datasets and publications containing skin permeation data available in the 
public domain which additionally includes associated experimental protocols wherever available.
Methods
We performed a rigorous search and analysis of the original publications that reported skin permeability values 
to create a comprehensive, systematic and structured database.
Data content and organisation. Inclusion criteria for the data from a publication were as follows:
•	 publication was accessible in the public domain
•	 publication was the primary source of the data
•	 the kp value was reported in the paper or it was possible to calculate it from the given steady-state flux and 
concentration by division (for the sake of data uniformity, huskinDB contains logarithmic kp values measured 
in cm/s)
•	 data was discarded if no quantitative kp value was reported and it was obtainable only from the plots in the 
publication
•	 permeation was measured using undamaged human skin and aqueous solution (in some cases with the addi-
tion of ethanol or methanol or in organic solvent) or neat compound.
If the publication satisfied the criteria mentioned above, the following experimental parameters were taken 
from it in addition to the kp value:
•	 name of the compound
•	 whether the skin was obtained during a surgical procedure or from a cadaver
•	 site of the body from which skin was excised
•	 skin preparation technique
•	 layer of the skin
•	 storage temperature
•	 storage duration
•	 whether the compound was tested neat or as a solution
•	 temperature of the donor solution
•	 pH of the donor solution
•	 type of the donor solution
•	 temperature of the acceptor solution
•	 pH of the acceptor solution
•	 type of the acceptor solution
•	 type of the permeation cell
•	 steady-state flux and concentration of the compound (if used for skin permeation calculation)
If parameters were unknown, the corresponding fields were left empty. Apart from the compound name, 
huskinDB contains canonical SMILES that were generated using Open Babel version 2.4.1 (http://openbabel.org)24.
For the purpose of data analysis, molecular weights and octanol/water partition coefficients (logP) were calculated 
using the RDKit version 2019.09.3 (https://github.com/rdkit/rdkit) library for Python (http://www.python.org).
Data records
Conducted work has led to the development of the “Human Skin DataBase- huskinDB” (huskinDB25, https://doi.
org/10.7303/syn21998881). As of April 2020, huskinDB25 contains 546 kp values for 251 different compounds cov-
ering 94 publications. This data can be accessed also via huskinDB homepage (https://huskindb.drug-design.de). 
On the huskinDB website, the user has full access to the records in the “Database” section and can perform 
searches. It is possible to define a custom set of rules to filter the data. If a specific compound is selected, all 
data on this compound is shown on a separate page. In the “Search” section of the huskinDB website, it is pos-
sible to draw a custom molecule using Marvin JS (https://chemaxon.com/products/marvin-js) and search for 
ten best matching compounds in the database (see Fig. 1). The content of the tables can be downloaded in the 
form of a CSV-file. Online-only Table 1 gives an overview of the experimental parameters and associated values 
that describe conditions under which skin permeation values were obtained. These parameters are discussed in 
greater detail below and correspond to the structure and the content of the downloadable CSV files.
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Compound name. The database contains one name per compound. Only one name was chosen if a different 
name for the same compound was used in different publications. As shown in Online-only Table 1, the most 
frequently tested compound was testosterone with 16 data points. The second most frequent were estradiol and 
water with 15 data points each.
Skin donor type. Almost half of the skin permeation measurements were assessed using cadaver skin. The 
rest of the skin was obtained as a result of surgical procedures. The records also specify the type of surgical proce-
dure. If the publication describes using skin from different sources, all of them are given. For example, Anderson 
et al.26 describe using skin obtained from a cadaver or during abdominoplasty. Therefore, the corresponding 
record is “Abdominoplasty or cadaver”.
Body site (skin source). Excised abdominal skin was used most frequently, obtained either as a result of 
abdominoplasty, e.g. Legoabe et al.27, or removed from a cadaver, e.g. Blank et al.28. Different sites are listed if 
different sources were reported in the publication, e.g. Johnson et al.29 used skin that was removed from the chest, 
back and abdomen.
Skin preparation technique. Heat separation was the most frequent method used to prepare the skin. 
With this technique, previously obtained skin tissue is heated in water at 60°C for one minute, which leads to a 
separation of the epidermis30. The second most frequently reported technique was cutting the skin in different 
thicknesses using a dermatome - an instrument that cuts the upper layer of the skin of defined thickness31. If 
the thickness of the dermatomed skin was reported, it was noted in the database. If the authors used dermat-
omed skin but did not report the obtained thickness, no thickness is given, for example, Kushla et al.32 used 
Fig. 1 The search section on the huskinDB website allows users to draw a custom molecule and search for 
similar structures in the database. The user is also able to download the data from any table in the form of either 
a CSV or Excel file.
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dermatomed skin of thickness 150μm and the corresponding entry “dermatomed 150μm” can be found in the 
in huskinDB, Boogaard et al.33 did not specify the thickness of dermatomed skin and as such the corresponding 
entry reads “dermatomed”.
Layer of the skin used. Analysis of the original publications revealed that research groups used different 
skin layers to obtain permeability values. As described in the introduction, skin layers have different properties 
with respect to their absorption of chemicals. This has been recognised by many researchers26,34–36. Therefore, it 
was important for us to include this parameter in the database. If the layer was reported in the original publi-
cation, it was directly transferred to huskinDB. Otherwise, the type of the layer was determined from the skin 
preparation technique, and the body site as follows: if heat separation was used, the corresponding entry is “epi-
dermis”30, if the authors wrote that the skin was “cut and placed”, “fat removed” or “dermatomed” without spec-
ifying the dermatome thickness, the corresponding entry is “epidermis, dermis”. Otherwise, information from 
Table 1 was used if the authors reported the thickness of the dermatomed skin and the skin source site. Analysis 
of the collected data shows that the most frequently used layer was epidermis, followed by epidermis with dermis. 
This can be explained through the use of heat separation (most frequently used preparation technique) and der-
matome (second most frequently used preparation technique) respectively.
The Flux and Notes columns give optional additional information. The first contains steady-state flux and con-
centration values which were used to calculate skin permeation if it was not directly reported in the publication 
(by division of the flux value by the concentration). The second one gives clarification on data point obtainment 
or processing if it was deviating from the overall data point obtainment protocol, e.g. if the kp measurements was 
obtained using a suspension as a donor medium.
Other parameters were directly transferred from the original publications.
huskinDB25 database is licensed under a Creative Commons Attribution 4.0 International License.
technical Validation
The following steps were performed in order to confirm that the records in huskinDB are correctly transferred 
from the original publications: first, the collected skin permeation values were compared to the ones reported 
in other data sets if these data sets contained skin permeation values from the same publication. After that, the 
correctness and completeness of all records was controlled by double-checking the content of the publications 
which reported experimental data. On this stage of validation errors in approximately 4% of records were iden-
tified and corrected. Next, after the initial compilation of huskinDB, all data records were double-checked twice 
by two different scientists. This validation did not reveal any errors in the data. Subsequently, a random collection 
of data points (approximately 10%) has been chosen and double-checked once again. No errors were identified 
on this stage as well.
Usage Notes
One of the aims of creating the huskinDB was to facilitate the development of in silico methods for predicting skin 
permeation or to gain additional knowledge of processes behind skin permeation. If developed, such predictive 
models or insights need to specify their applicability domain, which describes the chemical space in which valid 
predictions can be performed or to which some hypothesis is applicable37–39. This applicability domain directly 
depends on the database that is used to create predictive models. During an analysis of the previously created 
models for skin permeation, molecular weight and octanol/water partition coefficient were identified as typical 
descriptor variables13,23,40–42. These two descriptors were also found to improve the accuracy of logkp predicting 
models that were developed in-house. Therefore, molecular weight and octanol/water partition coefficient were 
chosen to analyse the applicability domain of huskinDB. Additionally, skin permeation value (logkp) was used to 
evaluate the chemical space since applicability domain is bound to its target variable. Below, a brief description of 
Skin source site Layer Thickness (μm) Reference
All
Stratum corneum 14.8 45





Stratum corneum 6.3 46




Epidermis with dermis 1032–1220 48
Back
Stratum corneum 8.4 46
Bottom dermal papillae 75.1 46
Epidermis 55.6 46
Breast Epidermis 419 49
Table 1. Thickness of different skin layers can differ depending on the skin source site. Combining the 
information on the skin source site and thickness can help to assess which layers were used in experiments.
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the chemical space of a hypothetical model or hypothesis, that is acquired using the full huskinDB dataset is pro-
vided. Obtained skin permeation values range between −11.436 (cm/s) (Propranolol hydrochloride) and −1.778 
(cm/s) (1-Nonalol) with a mean value of −6.36 (cm/s) (SD = 1.36, SE = 0.059). This is illustrated in Fig. 2(a), 
where logkp values in the histogram form a skewed Gaussian distribution. Digitoxin (764.4) and disodium octab-
orate tetrahydrate (590.0) show the largest molecular weight, whilst water (18.0) and methanol (32.0) form the 
lower molecular weight limit. A histogram of molecular weights in Fig. 2(b) shows a bias towards compounds 
with lower values. A plot of molecular weight against logkp in Fig. 2(c) reveals that the coverage of the chemical 
space is non-homogeneous.
For chemical space analysis, 8,697 molecules were obtained from the DrugBank version 5.0.1143 (37 molecules 
were omitted: it was either not possible to process them with RDKit, or their molecular weight was larger than 
2,500 or their calculated logP was higher than 20 or less than −20). The distribution of data from DrugBank and 
huskinDB over molecular weight and octanol/water partition coefficient (calculated with RDKit) in Fig. 3 illus-
trates that compounds from huskinDB only represent a subset of the DrugBank molecules: they show a smaller 
spread on both axes and represent molecules with relatively small weights.
Additional information on experimental conditions in huskinDB can be used to explain phenomena that 
were not correctly interpreted or understood before. In the following example, this use case is shown on the skin 
permeation values of three steroid subsets that were found by research groups to be inconsistent with other meas-
urements: 1995, Barratt et al.10 identified 12 measurements of hydrocortisone derivatives in the Flynn dataset that 
Fig. 2 Distribution of all logkp values (a), distribution of molecular weight values (b) and plot of molecular 
weights against logkp values (c) show that huskinDB does not represent all types of molecules equally well.
Fig. 3 Comparison of DrugBank and huskinDB data over molecular weight and calculated logP (Wildman-
Crippen logP) shows that a hypothetical model that is based on all huskinDB compounds, will not give equally 
reliable predictions for all compounds in DrugBank.
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were described as outliers. All of these measurements were performed by the same research group - Anderson 
et al.26 (further referred to as Anderson steroids). Later, Abraham et al.44 reported that the permeation values of 
steroids measured by Scheuplein et al.5 (Scheuplein steroids) are too low in comparison to more recent values 
published by Johnson et al.29 (Johnson steroids). To assess the correctness of both steroid data subsets, Abraham 
et al.44 developed a model that was not based on any of these values and evaluated its predictions. Abraham et al.44 
showed that predictions are in better agreement with Johnson’s data. Another interesting observation was made 
by Abraham et al., who suggested that Anderson steroids have kp values that are too high.
Figure 4 shows the relationship between logkp values and the molecular weight of three steroid subsets. The 
permeation values of different groups are clustered; however, when analysed more closely, it is apparent that the 
data points are grouped based on the molecular weights. Further data analysis reveals that these values were 
obtained using different skin layers. Permeation of Scheuplein and Johnson steroids were measured using epi-
dermis, whereas Anderson steroids were measured using thinner layer- stratum corneum. This means that the 
difference in the skin permeability between the steroid subsets might be caused by the difference in molecular 
weights on the one hand and by different skin layers on the other.
This demonstrates that the application area of huskinDB goes beyond permeation value prediction. It can also 
be used to assess the influence of experimental variables on the kp value. However, it must be noted that huskinDB 
contains molecules with small molecular weights in comparison to databases such as DrugBank43. Apart from 
that, data on experimental protocols of many measurements is unknown. Therefore, a direct comparison of the 
data points is not always possible. For example, misleading conclusions can be drawn when comparing two meas-
urements with one obtained using aqueous solution and another using unknown donor medium, which may be 
non-aqueous. Careful analysis of the skin membrane with respect to the lipophilicity of the chemical compound 
is advised as well when looking at a specific skin permeation measurement. A skin membrane consisting solely 
of stratum corneum will provide a weaker barrier function than a membrane consisting of the whole epidermis 
and dermis, especially for the lipophilic compounds since the hydrophilic viable epidermis may become the 
rate-determining factor.
Also, we would like to point out that the user might not be interested in the kp value itself, rather in the flux 
values across the skin. These values might provide a descriptor more adequate for estimation of the compound 
intake during, for example, occupational exposure and can be calculated by multiplication of the kp value by the 
compound concentration in the donor medium. Given that the compound solubility is used as the concentration, 
one might calculate the theoretical maximum flux. The solubility, in its turn, is dependent on the medium in 
which the compound is dissolved. This also denotes the importance of the data point quality validation since the 
donor medium and thus the solubility is different across the data records in huskinDB, making direct kp value 
comparison rather challenging and, in some cases, even misleading. Different properties of different solvents also 
mean that the kp value of some compound obtained using one solvent, cannot be used to predict the flux value of 
the same compound in another solvent. Therefore, it is vital for the user to perform a proper data handling and 
Fig. 4 Steroids measured by Scheuplein, Johnson and Anderson are grouped in clusters. It is apparent that 
these researchers used compounds with different molecular weight classes and performed experiments with 
different skin layers; in green: Scheuplein steroids, in blue: Johnson steroids, in red: Anderson steroids; the layer 
of the skin that was used is shown by the shape of the marker – square: epidermis, diamond: stratum corneum. 
Scheuplein steroids, in blue: Johnson steroids, in red: Anderson steroids; the layer of the skin that was used is 
shown by the shape of the marker – square: epidermis, diamond: stratum corneum.
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to account for the limited chemical space and unknown values prior creating mathematical models or drawing 
conclusions from the data. In this regard, defining a custom set of rules would rank the data point suitability for 
one’s domain of interest in a tailored way. For example, a measurement obtained using a donor solution contain-
ing 90% ethanol or a measurement with many unknown parameters might be ranked as a “low confidence record” 
and excluded from further processing. In contrast, a data point obtained using common and known parameters 
such as phosphate-buffered saline as donor and acceptor medium at 37 °C and heat-separated epidermis would 
be ranked as a “high confidence record” and included in subsequent analysis. It is also important to note that 
more reliable data on compounds from different chemical classes would further expand the applicability domain 
of huskinDB. We plan to update the database, and therefore researchers are encouraged to submit their data to 
huskinDB, which provides a technical framework for the structured deposition of skin permeability data for small 
organic molecules.
Code availability
The code which was used to create Figs. 2–4 and analyse the data records in huskinDB can be found under the 
following link: https://github.com/RhDm/huskinDB_publication This repository contains a detailed guide on 
how to install the requirements and run the code.
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